Quality & complianceOfficial
Denmark flags Aimovig 140 mg supply problems linked to manufacturing issues
🇩🇰 DKMA · Wed 18 Nov 2026
The Danish Medicines Agency reports current supply difficulties with Novartis's erenumab 140 mg pre-filled pen, expected to last from mid-November to early December 2026.
The Danish Medicines Agency (DKMA) has published a supply notice for Aimovig 140 mg solution for injection in pre-filled pen, marketed in Denmark by Novartis Healthcare A/S. The notice is dated 18 November 2026 and states that there are current problems with supply.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.
More Quality & compliance
All →
BfArM publishes urgent field safety notice for Bentley InnoMed's BeFlow Iliac Covered Stent System
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM lists Siemens field safety notice for Dimension Urine Barbiturate Screen assay
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes Medtronic MiniMed urgent field safety notice for MiniMed Go app
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Merit Medical field safety notice for Philips BridgeT Balloon Prep Kit
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Urgent Field Safety Notice for Biomet UK's Avantage Cup Gripper
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes InterSystems field safety notice for TrakCare France software
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026